<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1d3" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">65834</article-id><article-id pub-id-type="doi">10.7554/eLife.65834</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Computational and Systems Biology</subject></subj-group><subj-group subj-group-type="heading"><subject>Epidemiology and Global Health</subject></subj-group></article-categories><title-group><article-title>Osteogenic growth peptide is a potent anti-inflammatory and bone preserving hormone via cannabinoid receptor type 2</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes" id="author-218950"><name><surname>Raphael-Mizrahi</surname><given-names>Bitya</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-8629-1088</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="corresp" rid="cor1">*</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-22852"><name><surname>Attar-Lamdar</surname><given-names>Malka</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-219910"><name><surname>Chourasia</surname><given-names>Mukesh</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-219916"><name><surname>Cascio</surname><given-names>Maria G</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-219917"><name><surname>Shurki</surname><given-names>Avital</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-69175"><name><surname>Tam</surname><given-names>Joseph</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-0948-0093</contrib-id><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-219918"><name><surname>Neuman</surname><given-names>Moshe</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-94229"><name><surname>Rimmerman</surname><given-names>Neta</given-names></name><xref ref-type="aff" rid="aff6">6</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-87241"><name><surname>Vogel</surname><given-names>Zvi</given-names></name><xref ref-type="aff" rid="aff6">6</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-219919"><name><surname>Shteyer</surname><given-names>Arie</given-names></name><xref ref-type="aff" rid="aff7">7</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-219920"><name><surname>Pertwee</surname><given-names>Roger G</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-150216"><name><surname>Zimmer</surname><given-names>Andreas</given-names></name><xref ref-type="aff" rid="aff8">8</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-219908"><name><surname>Kogan</surname><given-names>Natalya</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-22854"><name><surname>Bab</surname><given-names>Itai</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-67683"><name><surname>Gabet</surname><given-names>Yankel</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-7494-0631</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="corresp" rid="cor2">*</xref><xref ref-type="other" rid="par-1"/><xref ref-type="other" rid="par-2"/><xref ref-type="other" rid="par-3"/><xref ref-type="other" rid="par-4"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><institution content-type="dept">Department of Anatomy and Anthropology</institution>, <institution>Tel Aviv University</institution>, <addr-line><named-content content-type="city">Tel Aviv</named-content></addr-line>, <country>Israel</country></aff><aff id="aff2"><institution content-type="dept">Institute of Dental Sciences, Faculty of Dental Medicine</institution>, <institution>Hebrew University of Jerusalem</institution>, <addr-line><named-content content-type="city">Jerusalem</named-content></addr-line>, <country>Israel</country></aff><aff id="aff3"><institution content-type="dept">Institute for Drug Research, Faculty of Medicine</institution>, <institution>Hebrew University of Jerusalem</institution>, <addr-line><named-content content-type="city">Jerusalem</named-content></addr-line>, <country>Israel</country></aff><aff id="aff4"><institution content-type="dept">Institute of Medical Sciences</institution>, <institution>University of Aberdeen</institution>, <addr-line><named-content content-type="city">Aberdeen</named-content></addr-line>, <country>United Kingdom</country></aff><aff id="aff5"><institution content-type="dept">Institute for Drug Research, School of Pharmacy, Faculty of Medicine</institution>, <institution>Hebrew University of Jerusalem</institution>, <addr-line><named-content content-type="city">Jerusalem</named-content></addr-line>, <country>Israel</country></aff><aff id="aff6"><institution content-type="dept">Department of Neurobiology</institution>, <institution>Weizmann Institute of Science</institution>, <addr-line><named-content content-type="city">Rehovot</named-content></addr-line>, <country>Israel</country></aff><aff id="aff7"><institution content-type="dept">Department of Oral and Maxillofacial Surgery</institution>, <institution>Hebrew University of Jerusalem</institution>, <addr-line><named-content content-type="city">Jerusalem</named-content></addr-line>, <country>Israel</country></aff><aff id="aff8"><institution content-type="dept">Institute of Molecular Psychiatry</institution>, <institution>University of Bonn</institution>, <addr-line><named-content content-type="city">Bonn</named-content></addr-line>, <country>Germany</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-73636"><name><surname>Zaidi</surname><given-names>Mone</given-names></name><role>Reviewing editor</role><aff><institution>Icahn School of Medicine at Mount Sinai</institution>, <country>United States</country></aff></contrib></contrib-group><author-notes><corresp id="cor1"><label>*</label>For correspondence: <email>bityar@tau.ac.il</email> (BR);</corresp><corresp id="cor2"><label>*</label>For correspondence: <email>yankel@tauex.tau.ac.il</email> (YG);</corresp></author-notes><pub-date date-type="pub" publication-format="electronic"><day>23</day><month>05</month><year>2022</year></pub-date><volume>11</volume><elocation-id>e65834</elocation-id><history><date date-type="received"><day>16</day><month>12</month><year>2020</year></date><date date-type="accepted"><day>22</day><month>05</month><year>2022</year></date></history><permissions><copyright-statement>Â© 2022, Raphael-Mizrahi et al</copyright-statement><copyright-year>2022</copyright-year><copyright-holder>Raphael-Mizrahi et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link> permitting unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-65834-v1.pdf"/><abstract><p>The endocannabinoid system consists mainly of 2-arachidonoylglycerol and anandamide, as well as cannabinoid receptor type 1 (CB1) and type 2 (CB2). Based on previous studies, we hypothesized that a circulating peptide previously identified as Osteogenic Growth Peptide (OGP) maintains a bone-protective CB2 tone. We tested OGP activity in mouse models and cells, and in human osteoblasts. We show that the OGP effects on osteoblast proliferation, osteoclastogenesis, and macrophage inflammation <italic>in vitro</italic>, as well as rescue of ovariectomy-induced bone loss and prevention of ear edema <italic>in vivo</italic> are all abrogated by genetic or pharmacological ablation of CB2. We also demonstrate that OGP binds at CB2 and may act as both an agonist and positive allosteric modulator in the presence of other lipophilic agonists. In premenopausal women, OGP circulating levels significantly decline with age. In adult mice, exogenous administration of OGP completely prevented age-related bone loss. Our findings suggest that OGP attenuates age-related bone loss by maintaining a skeletal CB2 tone. Importantly, they also indicate the occurrence of an endogenous peptide that signals via CB2 receptor in health and disease.</p></abstract><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Human</kwd><kwd>Mouse</kwd></kwd-group><funding-group><award-group id="par-1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100003977</institution-id><institution>Israel Science Foundation</institution></institution-wrap></funding-source><award-id>1822/12</award-id><principal-award-recipient><name><surname>Gabet</surname><given-names>Yankel</given-names></name></principal-award-recipient></award-group><award-group id="par-2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100003977</institution-id><institution>Israel Science Foundation</institution></institution-wrap></funding-source><award-id>1367/12</award-id><principal-award-recipient><name><surname>Gabet</surname><given-names>Yankel</given-names></name></principal-award-recipient></award-group><award-group id="par-3"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100003977</institution-id><institution>Israel Science Foundation</institution></institution-wrap></funding-source><award-id>1086/17</award-id><principal-award-recipient><name><surname>Gabet</surname><given-names>Yankel</given-names></name></principal-award-recipient></award-group><award-group id="par-4"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100010874</institution-id><institution>American Society for Bone and Mineral Research</institution></institution-wrap></funding-source><award-id>Gap award</award-id><principal-award-recipient><name><surname>Gabet</surname><given-names>Yankel</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group></article-meta></front><back><sec id="s1" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interest</title><fn fn-type="conflict" id="conf1"><p>The authors declare that no competing interests exist.</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>Animal experimentation: Animals - C57BL/6J mice were used in all experiments. All procedures involving animals were carried out in accordance with the institutional guidelines and were approved by the Institutional Animal Care and Use Committee of Tel Aviv University (permit number M-14-092) and the Hebrew University of Jerusalem (permit number MD-12-13458-3). Cnr2 knockout (Cnr2-/-) were generated and shipped from the University of Bonn (Germany) and bred in the respective animal facilities at the Hebrew University and Tel Aviv University (SPF unit).</p></fn><fn fn-type="other"><p>Human subjects: Human osteoblasts - The cells were obtained from patients undergoing total hip replacement (Helsinki ethics approval 0063-12-TLV).Human serum - The protocol was designed in accordance the institutional guidelines and with the approval of the Institutional Research Committee for Human Studies of the Hebrew University-Hadassah Medical Centre.We declare that a written informed consent was received from all participants prior to inclusion in this study.</p></fn></fn-group></sec><sec id="s2" sec-type="supplementary-material"><title>Additional Files</title><sec id="s3" sec-type="data-availability"><title>Data availability</title><p>All data generated or analyzed during this study are included in the manuscript and supporting files. Source data files have been provided for Figures 1 and 2 and 4-8.</p></sec><supplementary-material><ext-link xlink:href="elife-65834-supp-v1.zip">Download zip</ext-link><p>Any figures and tables for this article are included in the PDF. The zip folder contains additional supplemental files.</p></supplementary-material></sec></back></article>